Skip to content
ABL

Abacus Global Management, Inc.

Abacus Global Management, Inc. Q3 FY2025 earnings call

November 6, 2025 · fiscal period ended 2025-09

EPS · actual vs est

$0.20 / $0.18Beat +11.1%

Revenue · actual vs est

$63.0M / $55.8MBeat +12.9%
Ask about this call

Summary

Generated 2025-11-06

Management highlights

• Delivered record third quarter results with total revenue up 124% YOY to $63 million, adjusted net income up 60% to $23.6 million, and adjusted EBITDA up 127% to $37.9 million. • Initiated an annual dividend of $0.20 per share and a $10 million share repurchase program. • Announced a $50 million above investment-grade securitization product note backed by life insurance assets. • Acquired AccuQuote, a premier online life insurance brokerage, which will serve as a scalable growth engine. • Longevity-based assets are uncorrelated to traditional markets, driven by actuarial and demographic trends. • Balance sheet and cash generation at record levels, supported by increasing capital inflows into longevity funds, growing fee income, and expanding margins.

View in transcript ↓

Segment performance

Total revenue increased 124% year-over-year to $63 million. The Life Solutions segment saw capital deployed increase 10% to $102.4 million in Q3, with realized gains of $46.4 million and 522 policies valued at $424.7 million on the balance sheet. The Asset Management segment generated $8.6 million in revenue during Q3 with $102 million of new inflows. Technology Services contributed to the overall revenue growth.

View in transcript ↓

Guidance

• Raised 2025 guidance to $80 million to $84 million, resulting in a year-over-year growth of 72% to 81% for 2025. • Expect to continue funding strategic initiatives while returning capital to shareholders.

View in transcript ↓

Risks

• Risks associated with forward-looking statements, which if materialize could materially affect results. • Market uncertainties and regulatory risks that could impact the business.

View in transcript ↓

Q&A highlights

Q: Could we see larger securitizations going forward, maybe upwards of like $75 million?

A: Yes, we will see larger securitizations over time as the platform is effective and there is excess demand.

Q: How quickly do the lives turn from in trial to paid for ABL?

A: Typically turns within the quarter, with the underlying pipeline for number of lives being significant, on track for north of 3 million lives by end of Q4.

View in transcript ↓

Key numbers

Reported versus consensus

Earnings calendar feed

MetricReportedConsensusDeltaPrior year
EPS$0.20$0.18+11.1%
Revenue$63.0M$55.8M+12.9%

Transcript

November 6, 2025

Full transcript unavailable for redistribution

The structured summary above covers the available call sections. Full transcript text is not included on this page.

Continue exploring

Prior quarters

This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.